NMM
NBIX icon

Naples Money Management’s Neurocrine Biosciences NBIX Stock Holding History

Naples Money Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.23K Hold
28
– – ﹤0.01% 267
2024
Q2 		$3.92K Hold
28
– – ﹤0.01% 252
2024
Q1 		$3.86K Sell
28
-4
-13% -$546 ﹤0.01% 254
2023
Q4 		$4.22K Buy
+32
New +$3.68K ﹤0.01% 265

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Naples Money Management's NBIX Position: Q3 2024 in Review

Naples Money Management held its Neurocrine Biosciences (NBIX) position steady in Q3 2024 at 28 shares worth $3.23K. The position accounts for ﹤0.01% of the portfolio, ranked #267.

Naples Money Management first reported a position in NBIX in Q4 2023 and has held it in 4 quarters since. The position peaked at $4.22K in Q4 2023. 575 funds tracked by Wall St. Rank hold NBIX as of Q3 2024.

  • Naples Money Management held 28 shares of Neurocrine Biosciences worth $3.23K as of Q3 2024.
  • Naples Money Management left its Neurocrine Biosciences share count unchanged in Q3 2024.
  • Neurocrine Biosciences made up ﹤0.01% of Naples Money Management's portfolio in Q3 2024, its #267 holding.
  • Naples Money Management first reported a position in Neurocrine Biosciences in Q4 2023 and has held it in 4 quarters since.
  • Naples Money Management's Neurocrine Biosciences position peaked at $4.22K in Q4 2023.
  • 575 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2024.

Based on Naples Money Management's 13F filing for Q3 2024, filed 12 Nov 2024.